Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Buprenorphine
|
| gptkbp:appointed_by |
once daily
sublingual film |
| gptkbp:approves |
gptkb:2002
gptkb:FDA |
| gptkbp:can_be_used_with |
counseling
behavioral therapies |
| gptkbp:caused_by |
withdrawal symptoms
dependence |
| gptkbp:contains |
gptkb:naloxone
gptkb:buprenorphine |
| gptkbp:contraindication |
hypersensitivity to buprenorphine
severe respiratory depression acute or severe liver impairment |
| gptkbp:developed_by |
gptkb:Reckitt_Benckiser
|
| https://www.w3.org/2000/01/rdf-schema#label |
Suboxone
|
| gptkbp:interacts_with |
gptkb:beer
CNS depressants benzodiazepines |
| gptkbp:is |
a cure for addiction
a standalone treatment recommended for use in patients with severe liver disease a full agonist opioid a substitute for illicit opioids recommended for use in patients with a history of substance use disorder without supervision recommended for acute pain management recommended for use in children under 16 years old recommended for use in pregnancy without consultation recommended for use in patients with a history of hypersensitivity reactions |
| gptkbp:is_available_in |
tablet form
various dosages film form |
| gptkbp:is_available_on |
generic medication
|
| gptkbp:is_considered |
a safer alternative to full agonist opioids
a mixed agonist-antagonist a partial agonist effective in preventing withdrawal symptoms effective in reducing cravings |
| gptkbp:is_part_of |
harm reduction strategies
integrated care approach comprehensive treatment plan opioid use disorder treatment |
| gptkbp:is_subject_to |
abuse potential
regulation by DEA |
| gptkbp:is_used_by |
physicians
|
| gptkbp:is_used_for |
opioid addiction treatment
|
| gptkbp:is_used_in |
rehabilitation centers
detoxification programs long-term treatment plans |
| gptkbp:requires |
supervision by healthcare provider
|
| gptkbp:side_effect |
headache
nausea constipation sweating |
| gptkbp:used_in |
medication-assisted treatment (MAT)
|